These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [The use of synthetic antiparkinson agents as antidepressive agents]. Wirth JF Ann Med Psychol (Paris); 1979; 137(3-4):245-50. PubMed ID: 496148 [No Abstract] [Full Text] [Related]
11. [The effectiveness of the use of new types of antiparkinson agents]. Federmann J; Honzáková L; Roth B; Stika L Cesk Zdrav; 1981 Jun; 29(6):229-41. PubMed ID: 7261170 [No Abstract] [Full Text] [Related]
13. [Complications of drug withdrawal from antiparkinson agents and neuroleptics]. Mizon JP; Rosa A Therapie; 1984; 39(4):421-5. PubMed ID: 6148792 [No Abstract] [Full Text] [Related]
14. [Does a specific withdrawal syndrome from non-dopaminergic antiparkinson agents exist?]. George V; Castot A; Bidault I Therapie; 1987; 42(4):339-41. PubMed ID: 3686467 [No Abstract] [Full Text] [Related]
15. [Synthesis and testing of potential antiparkinson agents. 1. Biolgocially active silicone compounds]. Kuhrt G; Matthies H; Liebmann H; Rühlmann K Pharmazie; 1976; 31(12):849-51. PubMed ID: 1023260 [No Abstract] [Full Text] [Related]
16. [1 model for the prognosis of anticonvulsive and antiparkinson agents]. Ianishevs'ka NO; Piniazhko RM Farm Zh; 1978; (6):68-72. PubMed ID: 729766 [No Abstract] [Full Text] [Related]